Industry Reports
Pfizer Entering into a partnership with Laboratorio Teuto Brasileiro S.A to develop and commercialize generic medicines
Pfizer Inc. announced that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A., a leading company in the Brazilian generics industry, to develop and commercialize generic medicines. Pfizer will acquire a 40 percent stake in Teuto and...
Industry Reports
Genzyme Reports Financial Results for the Third-quarter revenue was $1.0 billion,
Genzyme Corp. reported third-quarter earnings growth driven by increased shipments of Cerezyme® (imiglucerase for injection). Patients in the United States began returning to normal dosing levels last month, and patients globally are expected to be able to do so...
Industry Reports
Teva to Report Third Quarter 2010 Financial Results on November 2, 2010
Teva Pharmaceutical Industries Ltd. announced that it will release its third quarter 2010 financial results on Tuesday, November 2, 2010. Teva will host a conference call and live webcast on the same day, at 8:30 a.m....
Industry Reports
Cephalon Reports Record Sales – Quaterly sales increased 32% percent
Cephalon, Inc. reported second quarter 2010 sales of $712.4 million, a 32 percent increase compared to sales of $539.0 million for the second quarter 2009. Basic income per common share for the quarter was $1.18. Excluding amortization expense and...
Industry Reports
Ranbaxy Achieves USD 1 Billion Revenue
The Board of Directors of Ranbaxy Laboratories Limited (RLL) at their meeting held today, took on record the unaudited results for the quarter ended June 30, 2010 (the “Quarter”). Key Financial HighlightsFinancial Performance for the quarter...
Industry Reports
King Pharmaceuticals, Inc announced total revenue for the second quarter ended June 30, 2010
King Pharmaceuticals, Inc.announced that total revenue for the second quarter ended June 30, 2010 equaled $371 million compared to $445 million in the second quarter of 2009. The Company reported net income of $18.0 million and diluted earnings per...
Industry Reports
Amylin Pharmaceuticals Reports Second Quarter Results total revenue of $164.4 for the quarter ended June 30, 2010
Amylin Pharmaceuticals, Inc. reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million. Net loss, excluding...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read